Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Exploring Mountains of Innovation in Northern New England
|
Ryan McBride |
11/03/09 |
Boston
|
|
Virdante Pharma Lands $30M in A Round to Combat Inflammation
|
Ryan McBride |
10/29/09 |
Boston
|
|
How to Tap Russia for Biomedical Breakthroughs: Lessons from Boston BioCom
|
Ryan McBride |
10/15/09 |
Boston
|
|
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/06/09 |
Seattle
|
|
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs
|
Luke Timmerman |
09/18/09 |
San Diego
|
|
Life Science Leaders Converge in Newport, PubGet Gets Your Paper Faster, I-Therapeutix Eyes $15M Prize & More Boston-Area Life Sciences News
|
Roxanne Palmer |
06/24/09 |
Boston
|
|
Celldex to Buy CuraGen for $94.5M
|
Ryan McBride |
05/29/09 |
Boston
|
|
Dendreon’s Manufacturing Challenge, Archus Cuts Deep, Accelerator Company Launches & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells
|
Ryan McBride |
05/18/09 |
Boston
|
|
Accelerator’s New Startup, Xori, Aims to Use Chicken Cells to Make Better Antibody Drugs
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Spaltudaq Now Theraclone Sciences
|
Luke Timmerman |
03/30/09 |
Seattle
|
|
Aveo and Biogen in Antibody Partnership
|
Ryan McBride |
03/24/09 |
Boston
|
|
CEO Gerngross Says Deals Around Adimab’s Yeast-Based Antibody Discovery Technology Are Progressing
|
Ryan McBride |
02/19/09 |
Boston
|
|
Dyax and Biogen Expand Pact
|
Ryan McBride |
02/05/09 |
Boston
|
|
Alexion Settles Legal Dispute
|
Ryan McBride |
01/05/09 |
Boston
|
|
Seattle Genetics Starts Clinical Trial of SGN-70 For Autoimmune Disease
|
Luke Timmerman |
07/31/08 |
Seattle
|
|
The Future of Biotech Is in Rabbits, Says Entrepreneur Johnny Stine
|
Luke Timmerman |
07/30/08 |
Seattle
|
|
Seattle Genetics Licenses Antibody-Drug Linking Technology to Daiichi Sankyo
|
Luke Timmerman |
07/08/08 |
Seattle
|
|
VLST Hires Paul Carter, Antibody Drug Expert, as New Chief Scientist
|
Luke Timmerman |
07/02/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
